Literature DB >> 17051560

Early recurrence of hepatitis C virus infection after liver transplantation.

Lydia M Petrovic1.   

Abstract

KEY CONCEPTS: 1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV should be known. 6. The natural history of recurrent HCV should be known. 7. The future role of ancillary studies beyond liver biopsy is assessed. Copyright 2006 AASLD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051560     DOI: 10.1002/lt.20942

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

Review 1.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  Liver transplantation: yesterday, today and tomorrow.

Authors:  Osman Abbasoglu
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

3.  Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.

Authors:  Masahiro Ohira; Kohei Ishiyama; Yuka Tanaka; Marlen Doskali; Yuka Igarashi; Hirotaka Tashiro; Nobuhiko Hiraga; Michio Imamura; Naoya Sakamoto; Toshimasa Asahara; Kazuaki Chayama; Hideki Ohdan
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

4.  A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.

Authors:  Ulf Neumann; Didier Samuel; Pavel Trunečka; Jean Gugenheim; Giorgio Enrico Gerunda; Styrbjörn Friman
Journal:  J Transplant       Date:  2012-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.